SOURCE: Imaging Diagnostic Systems, Inc.
FORT LAUDERDALE, FL--(Marketwire - Sep 13, 2012) - Imaging Diagnostic Systems, Inc. (OTCBB: IMDS), a pioneer in laser breast imaging, announced today that it has installed the first CTLM® system in Monterrey, Mexico at Centro Medico Ave through its exclusive distributor Sistemas de Diagnostico e Imagenologia de México S.A. de C.V.
General Manager of Sistemas de Diagnostico e Imagenologia de México S.A. de C.V. Adrian Treviño comments, "The recent installation at the prestigious Centro Medico Ave is part of our strategic plan for the future of CTLM in Mexico. The installation of this CTLM system, which is not available anywhere else in the country, is an important part of our commitment to the women of Mexico. CTLM benefits such as no radiation, no compression, and no injected contrast agents are expected to be a welcome addition to the Mexican health care system. Our dedicated and experienced team is ready to support this innovative 3D laser breast imaging modality. Through this and future installations, we look forward to assisting the imaging needs of women in Mexico."
Centro Medico Ave is a comprehensive state of the art medical center that offers first class facilities along with the finest and most distinguished physicians who are dedicated to diagnosing, treating and rehabilitating health. Its ongoing objective is to achieve excellence in every aspect of patient care.
"IDSI is honored and excited that Sistemas de Diagnostico e Imagenologia de México S.A. de C.V. has chosen Centro Medico Ave as the first CTLM site in Mexico," commented Linda Grable, CEO of IDSI. "We are pleased that the women of Mexico may soon benefit from non-invasive 3D laser breast imaging. We appreciate the hard work and dedication that the qualified team at Sistemas de Diagnostico e Imagenologia de México S.A. de C.V. has devoted to this installation. Mexico represents enormous potential and this is a huge step towards assisting women's health in Mexico by increasing the presence of CTLM there."
Imaging Diagnostic Systems, Inc. is the developer of the CTLM system; a revolutionary optical breast imaging device. Optical mammography is a diffuse optical tomography (DOT) technique that aims at detecting breast cancer. The CTLM system utilizes patented continuous wave laser technology and computed algorithms to create 3D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. The CTLM system has received certification and licenses to sell internationally through the following approvals; European CE marking, Health Canada, China SFDA, UL, ISO 13485:2003, FDA export certification. Marketing clearances pending are Mexico COFEPRIS and Russian GOST-R.
For more information, visit our website: www.imds.com
As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc. is included in the Company's filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.